Rossari Biotech Ltd

Rossari Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Rossari Biotech Ltd

₹ 544 0.87%
08 May - close price
rossari.com BSE: 543213 NSE: ROSSARI
About

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]

Their 3 main product categories are [2]:
- Home, personal care, and performance chemicals
- Textile specialty chemical
- Animal health and nutrition

The company has two R&D facilities, one at Silvassa manufacturing facility and a research lab at IIT Bombay. [3]

Key Points

Product Segments
The company is one of India’s leading specialty chemicals manufacturer offering 4,280+ products across 3 verticals: [1]

Website BSE NSE
  • Market Cap ₹ 3,013 Cr.
  • Current Price ₹ 544
  • High / Low ₹ 768 / 373
  • Stock P/E 21.1
  • Book Value ₹ 220
  • Dividend Yield 0.09 %
  • ROCE 16.4 %
  • ROE 12.4 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Company has a low return on equity of 11.5% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
264 258 332 299 314 301 336 368 427 366 420 451 516
228 223 290 258 272 261 292 318 374 322 369 400 453
Operating Profit 36 35 42 41 42 40 44 50 52 44 50 50 64
OPM % 14% 14% 13% 14% 13% 13% 13% 14% 12% 12% 12% 11% 12%
2 1 2 2 1 1 1 1 2 2 1 1 23
Interest 1 2 3 3 2 2 2 2 3 3 2 4 4
Depreciation 7 6 6 6 7 6 7 7 8 7 7 7 9
Profit before tax 30 29 36 35 35 33 37 41 44 35 42 40 74
Tax % 23% 26% 26% 27% 25% 26% 26% 26% 26% 26% 26% 24% 26%
23 22 26 26 26 24 27 31 32 26 31 31 55
EPS in Rs 4.20 3.91 4.78 4.62 4.74 4.40 4.96 5.53 5.84 4.74 5.64 5.53 9.88
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
122 178 233 292 516 600 690 1,073 975 1,203 1,432 1,752
108 166 209 247 438 495 569 950 853 1,042 1,245 1,544
Operating Profit 13 12 24 45 78 105 121 123 123 161 186 208
OPM % 11% 7% 10% 15% 15% 18% 18% 11% 13% 13% 13% 12%
0 0 1 1 1 4 10 13 4 7 6 27
Interest 3 3 2 1 3 4 3 3 5 10 10 13
Depreciation 5 4 4 5 12 17 22 26 26 24 28 31
Profit before tax 6 5 19 39 63 88 106 107 96 134 155 191
Tax % 11% 29% 17% 27% 28% 26% 25% 26% 25% 26% 26% 25%
5 3 16 29 46 66 79 79 71 100 115 143
EPS in Rs 11.59 7.77 35.43 65.73 104.07 12.91 15.23 14.43 12.94 18.04 20.72 25.79
Dividend Payout % 1% 0% 1% 0% 0% 4% 3% 3% 4% 3% 2% 2%
Compounded Sales Growth
10 Years: 26%
5 Years: 20%
3 Years: 22%
TTM: 22%
Compounded Profit Growth
10 Years: 45%
5 Years: 13%
3 Years: 26%
TTM: 26%
Stock Price CAGR
10 Years: %
5 Years: -16%
3 Years: -8%
1 Year: -19%
Return on Equity
10 Years: 14%
5 Years: 11%
3 Years: 12%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4 4 4 4 4 10 10 11 11 11 11 11
Reserves 27 41 56 85 116 273 394 774 848 949 1,066 1,207
38 22 24 22 9 67 0 0 65 68 50 144
24 37 37 49 119 118 140 141 202 253 324 401
Total Liabilities 93 104 122 160 248 468 544 926 1,126 1,281 1,451 1,764
43 36 37 44 74 94 171 177 157 167 179 218
CWIP 0 8 8 10 3 22 0 1 14 25 34 105
Investments 0 0 0 3 0 15 9 381 493 528 538 548
50 60 77 103 171 338 364 367 462 561 699 893
Total Assets 93 104 122 160 248 468 544 926 1,126 1,281 1,451 1,764

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 23 2 22 72 56 52 33 113 74 92 59
0 -5 -6 -16 -41 -187 -37 -318 -160 -70 -70 -101
0 -18 3 -6 -26 155 -29 297 61 -22 -32 79
Net Cash Flow 0 1 -0 -1 5 23 -14 12 14 -18 -10 36
Free Cash Flow 0 19 -3 8 28 -20 -4 3 92 24 39 -36
CFO/OP 0% 202% 22% 72% 118% 72% 68% 47% 112% 68% 71% 53%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 70 59 74 75 61 57 73 62 91 92 96 108
Inventory Days 77 70 52 65 59 57 72 48 58 61 62 50
Days Payable 83 79 70 71 114 95 100 52 92 92 100 102
Cash Conversion Cycle 63 50 56 69 6 19 44 58 58 61 58 56
Working Capital Days 78 11 23 42 20 22 61 63 52 67 72 69
ROCE % 27% 42% 55% 38% 29% 18% 12% 14% 15% 16%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Consolidated Installed Manufacturing Capacity
MTPA

Log in to view insights

Please log in to see hidden values.

Login
Capacity Utilization (Group/Consolidated)
%
Number of Employees (Total Workforce)
Number
Export Share of Revenue
%
Number of Distributors
Number
Number of Products in Portfolio
Number
R&D Spend
INR Million
Core B2B Segment Volume Growth (YoY)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
68.44% 68.35% 68.34% 68.32% 68.32% 68.27% 68.19% 68.18% 68.18% 68.18% 68.15% 68.15%
6.12% 5.74% 4.14% 4.02% 3.83% 3.74% 3.74% 3.98% 3.48% 2.70% 2.32% 2.18%
17.71% 17.68% 18.06% 17.74% 16.87% 17.34% 17.47% 17.59% 17.84% 18.18% 18.25% 18.21%
7.73% 8.23% 9.45% 9.90% 10.98% 10.64% 10.60% 10.24% 10.50% 10.95% 11.25% 11.46%
No. of Shareholders 95,37195,2001,00,42398,8591,00,47597,18895,73592,85291,79191,38789,24986,972

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls